#id week

Summit Therapeutics IDWeek 2021 E-Poster Provides Enhanced Details About the Newly Discovered Novel Mechanism of Action of Ridinilazole

Summit Therapeutics Inc.is today displaying an important e-Poster at IDWeek 2021. IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medical Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS), and the Society of Infectious Diseases Pharmacists (SIDP). Summit’s e-Poster provides…

Contagion®Interview with Ken Blount, PhD Chief Scientific Officer at Rebiotix, a Ferring Company, and Discussed the Phase II Microbiota Based RBX2660 Clinical Trial Results and Plans for Next Steps

OCT 03, 2019 | ALEXANDRA WARD

Contagion Live

To read the interview in its entirety – click on the following link to be redirected:

https://www.contagionlive.com/news/phase-2-results-microbiotabased-rbx2660-safe-efficacious-for-preventing-c-diff-recurrence

Investigators at IDWeek 2019 presented the final, 24-month analysis of data…

New antibiotics on the (near) horizon - a report from Josh Davis from recent USA #IDWeek18 @ASID #ACIPC18

Guest posting: Assoc. Prof. Josh Davis, President, Australasian Society for Infectious Diseases. @Guru_JoshD

“ID week” is a large US infectious diseases conference; this year it was in San Francisco, and had over 8,000 delegates. The most talked about trial at this conference (mentioned in at least 5 different sessions) was the Australian-led MERINO trial,an RCT which showed that…

Join the biggest Infectious Diseases Week 2017 at October 4 to 8 October 2017, more than 7000 Delegates are come to attend this conference and share knowledge or updates new technology. Many professionals like: doctors, patients, scientists and researchers are come to join this Id Week conference 2017. Congress Makers will help you to book all best facilities like: Hotel Booking, Transport and city tour.